🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates a personalized treatment strategy for patients with la...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Start Date
2026-05-14
Trial ID
NCT07602322
Treatments Being Tested
Multicentric phase 2 study for previously untreated high-risk CLL patients....
Status
Active Not Recruiting
Location
Ematologia AOU Careggi
Start Date
2023-07-21
Trial ID
NCT05478512
Treatments Being Tested
This is a single center, open label, single arm phase II clinical trial. Th...
Status
Recruiting
Location
Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital
Start Date
2024-07-10
Trial ID
NCT06471738
Treatments Being Tested
This open-label, multicenter, three cohorts, phase II study is designed to ...
Status
Recruiting
Location
Az Sint-Jan Brugge - Oostende Av
Start Date
2025-02-21
Trial ID
NCT06558604
Treatments Being Tested
The main objective of this study is to compare the efficacy of sonrotoclax ...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology, Llc
Start Date
2023-11-11
Trial ID
NCT06073821
Treatments Being Tested
This phase II trial studies the effects of venetoclax and rituximab in comp...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2022-01-05
Trial ID
NCT04840602
This is a Phase 1 dose-escalation study of PRT2527, a potent and highly sel...
Status
Completed
Location
City of Hope
Start Date
2023-09-12
Trial ID
NCT05665530
Treatments Being Tested
Bruton's tyrosine kinase inhibitors (BTKi), anti-CD20 antibodies, and the B...
Status
Active Not Recruiting
Location
Weill Cornell Medicine/NewYork-Presberteryian Hospital
Start Date
2023-05-08
Trial ID
NCT05650723
Treatments Being Tested
This is an open-label, multicenter, phase 2, non-randomized study aiming to...
Status
Recruiting
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Start Date
2025-12-01
Trial ID
NCT06958705
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirto...
Status
Completed
Location
Mayo Clinic of Scottsdale
Start Date
2019-03-15
Trial ID
NCT03740529
Treatments Being Tested